About: The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1989

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1989 (uk) article scientifique publié en 1989 (fr) im Februar 1989 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1989 (ast) artikull shkencor i botuar më 01 shkurt 1989 (sq) scientific article published on 01 February 1989 (en)
publication date	wds:Q61651766-E1D161D0-1846-4E9B-BAB2-54BC62DE263B
publication date	1989-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q61651766-A5303D71-1070-460E-A2D8-72AF38AD8396
language of work or name	English
cites work	wds:Q61651766-07A5B27F-33D7-4A0D-8B84-8CAE28FE9A1A wds:Q61651766-08A4E085-145D-4217-BEF6-2C361B44693A wds:Q61651766-28BFD018-1AB4-491E-8473-A14F199E93A6 wds:Q61651766-2ACA17FB-A843-400D-8733-81A6B1BB2CE8 wds:Q61651766-468525BB-ACDD-44D8-8E7F-40FB8446D675 wds:Q61651766-4DFEED5A-E962-4FE2-B0F1-33EE347722C6 wds:Q61651766-693DD203-BD02-4BC0-B7BC-09985F88B92D wds:Q61651766-69BEDB38-8E35-46D7-AD8E-503CDC693012 wds:Q61651766-7311AA10-0CC0-4993-9621-8541AC411B9B wds:Q61651766-74E8C082-5CF8-4F43-B314-8D9DFB568506 wds:Q61651766-809EDAA5-DBB2-4CC9-82AE-B73950AECDAE wds:Q61651766-849FD53E-6880-4870-92AB-C4F7455D7829 wds:Q61651766-E2615A7B-473E-46D6-A3AF-F5919CFFC3F5 wds:Q61651766-FC1D2004-A14D-483A-A7A6-E03FC660FA42 wds:Q61651766-FC29D90A-0055-4D66-B27F-81CA08A1107C wds:Q61651766-FD0216B0-28EE-4BED-A43C-38C7271438F3
cites work	Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants Aeronautics before 1919 Therapeutic potential of monovalent monoclonal antibodies Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody. The recovery of human polymorphonuclear leucocytes from sublytic complement attack is mediated by changes in intracellular free calcium Rat × rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies. Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells Fusion of Two Immunoglobulin-producing Myeloma Cells Univalent antibodies kill tumour cells in vitro and in vivo Bispecific monoclonal antibodies from hybrid hybridomas Hybrid hybridomas and the production of bi-specific monoclonal antibodies The internal image-like anti-idiotypic response to a CD3-specific monoclonal antibody in primates is dependent on the T cell-binding properties of the injected antibody
author name string	wds:Q61651766-236221EC-E09F-4A63-97C6-9DF0018D2942 wds:Q61651766-40C81533-8EE7-4F2B-911C-6E759C9D4E99 wds:Q61651766-CA3DFB01-C727-4C71-B120-FDC95DECF03C
author name string	Calne R Friend P Bindon C
rdfs:label	The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (en) The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (nl) The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (sq)
skos:prefLabel	The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (en) The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (nl) The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (sq)
name	The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (en) The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (nl) The improved lytic function andin vivo efficacy of monovalent monoclonal CD3 antibodies (sq)
author	wds:Q61651766-001E7227-6E11-43AA-A3C8-BFD3970CD6DF wds:Q61651766-61D43D1F-9594-4C6B-BC66-892E2FFC81C5 wds:Q61651766-AB693760-00D8-499E-BB42-01C09C632D28 wds:Q61651766-E7F1E6E7-C520-4F96-BDA9-69AA1DEC1C14 wds:Q61651766-FB0E2297-228D-4503-A399-F749792D865E
author	Herman Waldmann Stephen P. Cobbold Martin Dyer Geoff Hale Mike R. Clark
title	wds:Q61651766-AD5A9174-3F83-48A2-9BF5-BB6CB40F811D
title	The improved lytic function and in vivo efficacy of monovalent monoclonal CD3 antibodies (en)
page(s)	wds:Q61651766-ED603FC7-40B8-422E-A357-CFF56546022A
page(s)	381-388
instance of	wds:Q61651766-F7E13315-F5C5-4968-9271-24E08400FD20
instance of	scholarly article
PubMed ID	wds:Q61651766-E6D1861E-2BFB-4AE9-821A-597D2DC1615D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2522881
PubMed ID	2522881
published in	wds:Q61651766-4AA92055-7185-456A-9B99-F1716D7C699C
published in	European Journal of Immunology
issue	wds:Q61651766-1B56B2C1-C6D2-451A-A9F4-94A5BA96D309
volume	wds:Q61651766-874A83E2-F6D2-4C27-97DE-235953B2F541
issue	2
volume	19
DOI	wds:Q61651766-1E8010DB-E750-4047-89BA-FBA9CFED9225
DOI	http://dx.doi.org/10.1002/EJI.1830190224
DOI	10.1002/EJI.1830190224
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61651766
is cites work of	Human antibody effector function CD8 T cell activation after intravenous administration of CD3 x CD19 bispecific antibody in patients with non-Hodgkin lymphoma Unprimed CD4+ and CD8+ T cells can be rapidly activated by a CD3 x CD19 bispecific antibody to proliferate and become cytotoxic Killing of human leukaemia/lymphoma B cells by activated cytotoxic T lymphocytes in the presence of a bispecific monoclonal antibody (alpha CD3/alpha CD19) Microfluidic cell disruption system employing a magnetically actuated diaphragm Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain Selective induction of autocytotoxic activity through the CD3 molecule Lysine 322 in the human IgG3 CH2 domain is crucial for antibody dependent complement activation A mutant human IgG molecule with only one C1q binding site can activate complement and induce lysis of target cells. Complement activation by immunoglobulin does not depend solely on C1q binding Affinity purification of polyclonal antibodies using a new all-D synthetic peptide ligand: comparison with protein A and protein G Preparative electrophoresis: a general method for the purification of polyclonal antibodies

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software